Item Type | Name |
Concept
|
Tacrolimus
|
Concept
|
Tacrolimus Binding Proteins
|
Academic Article
|
Tacrolimus rescue therapy for renal transplant rejection.
|
Academic Article
|
Conversion from tacrolimus to cyclosporine--a based immunosuppression following liver transplantation.
|
Academic Article
|
Augmentation of natural chimerism with donor bone marrow in orthotopic liver recipients.
|
Academic Article
|
Tolerogenic immunosuppression for organ transplantation.
|
Academic Article
|
Non-lymphoid cancer after liver transplantation.
|
Academic Article
|
Small bowel transplantation: current progress and clinical application.
|
Academic Article
|
Evaluation of the influence of FK 506, rapamycin, and cyclosporine on processing and presentation of particulate antigen by macrophages: assessment of a drug "carry-over" effect.
|
Academic Article
|
FK 506 versus cyclosporine in pediatric liver transplantation.
|
Academic Article
|
Posttransplant lymphoproliferative disorders occurring under primary FK 506 immunosuppression.
|
Academic Article
|
Resolution of severe pyoderma gangrenosum in a patient with streaking leukocyte factor disease after treatment with tacrolimus (FK 506).
|
Academic Article
|
A prospective randomized trial of tacrolimus and prednisone versus tacrolimus, prednisone and mycophenolate mofetil in primary adult liver transplantation: a single center report.
|
Academic Article
|
Management of intestinal transplantation in humans.
|
Academic Article
|
Strategy of FK 506 therapy in liver transplant patients: effect of graft function.
|
Academic Article
|
Renal retransplantation in elderly recipients under tacrolimus-based immunosuppression.
|
Academic Article
|
Tacrolimus rescue therapy for renal allograft rejection--five-year experience.
|
Academic Article
|
De novo sirolimus and reduced-dose tacrolimus versus standard-dose tacrolimus after liver transplantation: the 2000-2003 phase II prospective randomized trial.
|
Academic Article
|
Cardiac changes at autopsy in adult liver transplant recipients under tacrolimus.
|
Academic Article
|
Pharmacokinetics of mycophenolic acid after mycophenolate mofetil administration in liver transplant patients treated with tacrolimus.
|
Academic Article
|
Bronchiolitis obliterans organizing pneumonia in a BMT patient receiving FK506.
|
Academic Article
|
Primary tacrolimus (FK506) therapy and the long-term risk of post-transplant lymphoproliferative disease in pediatric liver transplant recipients.
|
Academic Article
|
Tacrolimus enhances the immunosuppressive effect of cyclophosphamide but not that of leflunomide or mycophenolate mofetil in a model of discordant liver xenotransplantation.
|
Academic Article
|
Intestinal transplantation in composite visceral grafts or alone.
|
Academic Article
|
Systemic administration of CTLA4-Ig or anti-CD40 ligand antibody inhibits second-set rejection of mouse liver allografts.
|
Academic Article
|
Use of alemtuzumab and tacrolimus monotherapy for cadaveric liver transplantation: with particular reference to hepatitis C virus.
|
Academic Article
|
Effect of FK 506 on FK-binding protein and transforming growth factor beta gene expression.
|
Academic Article
|
Adverse effects associated with the use of FK 506.
|
Academic Article
|
The interaction between antiretroviral agents and tacrolimus in liver and kidney transplant patients.
|
Academic Article
|
FK 506 used as rescue therapy for human liver allograft recipients.
|
Academic Article
|
The Pittsburgh randomized trial of tacrolimus compared to cyclosporine for hepatic transplantation.
|
Academic Article
|
Kidney transplantation under minimal immunosuppression after pretransplant lymphoid depletion with Thymoglobulin or Campath.
|
Academic Article
|
Orthotopic liver transplantation in U.S. veterans under primary tacrolimus immunosupression.
|
Academic Article
|
Weaning of immunosuppression in liver transplant recipients.
|
Academic Article
|
Interaction between FK 506 and cyclosporine in dogs.
|
Academic Article
|
Retransplantation of liver: a comparison of FK 506- and cyclosporine-treated patients.
|
Academic Article
|
CMV infection in liver transplantation under cyclosporine or FK 506 immunosuppression.
|
Academic Article
|
Human islet allotransplantation under FK 506.
|
Academic Article
|
The induction of pseudo-graft-versus-host disease following syngeneic bone marrow transplantation using FK 506.
|
Academic Article
|
Efficacy of FK 506 in the treatment of recalcitrant pyoderma gangrenosum.
|
Academic Article
|
Allogeneic hematolymphoid microchimerism and prevention of autoimmune disease in the rat. A relationship between allo- and autoimmunity.
|
Academic Article
|
Xenotransplantation of hamster liver into Gunn rats reserves congenital hyperbilirubinemia.
|
Academic Article
|
Tacrolimus in renal transplantation.
|
Academic Article
|
Clinical small bowel or small bowel plus liver transplantation under FK 506.
|
Academic Article
|
Changes in renal function after liver transplantation under FK 506.
|
Academic Article
|
[Clinical experience with FK 506].
|
Academic Article
|
Pancreas transplantation under alemtuzumab (Campath-1H) and tacrolimus: Correlation between low T-cell responses and infection.
|
Academic Article
|
Chronic liver allograft rejection in a population treated primarily with tacrolimus as baseline immunosuppression: long-term follow-up and evaluation of features for histopathological staging.
|
Academic Article
|
Evidence of microchimerism after pretransplant blood transfusion and FK 506 in liver xenograft.
|
Academic Article
|
Prevention of sensitization and hyperacute rejection in liver and heart xenografts by FK 506 plus donor antigens.
|
Academic Article
|
Capillary blood versus arterial or venous blood for tacrolimus monitoring in liver transplantation.
|
Academic Article
|
Central venulitis in the allograft liver: a clinicopathologic study.
|
Academic Article
|
Outcome of kidney transplantation in African-Americans using tacrolimus.
|
Academic Article
|
The pharmacodynamics of pentobarbital following FK 506 therapy.
|
Academic Article
|
Renal function after conversion from cyclosporine to FK 506 in liver transplant patients.
|
Academic Article
|
The effect of cyclosporine, rapamycin and FK 506 the survival following allogeneic bone marrow transplantation.
|
Academic Article
|
FK 506: a new therapeutic agent for severe recalcitrant psoriasis.
|
Academic Article
|
FK506 in solid organ transplantation.
|
Academic Article
|
Prolonged survival of hearts obtained from chimeric donors in a mouse to rat xenotransplant model.
|
Academic Article
|
Results of pancreas transplantation after steroid withdrawal under tacrolimus immunosuppression.
|
Academic Article
|
Immune cell function testing: an adjunct to therapeutic drug monitoring in transplant patient management.
|
Academic Article
|
Xenogeneic humoral graft-Vs-host disease following hamster-to-Rat bone marrow transplantation.
|
Academic Article
|
Long-term follow-up of tacrolimus rescue therapy for renal allograft rejection.
|
Academic Article
|
Hematolymphoid cell trafficking, microchimerism, and GVH reactions after liver, bone marrow, and heart transplantation.
|
Academic Article
|
FK 506 prolongs survival of liver but not heart mouse-to-rat vascularized xenografts.
|
Academic Article
|
Complement and target cells belong to the same species after liver xenografting: protection from hyperacute rejection.
|
Academic Article
|
"Suboptimal" kidney donors: the experience with tacrolimus-based immunosuppression.
|
Academic Article
|
The long-term efficacy of multivisceral transplantation.
|
Academic Article
|
Five-year experience with tacrolimus rescue for renal allograft rejection.
|
Academic Article
|
FK506 "rescue" for resistant rejection of renal allografts under primary cyclosporine immunosuppression.
|
Academic Article
|
Long-term outcome of adding mycophenolate mofetil to tacrolimus for nephrotoxicity following liver transplantation.
|
Academic Article
|
Does tacrolimus offer virtual freedom from chronic rejection after primary liver transplantation? Risk and prognostic factors in 1,048 liver transplantations with a mean follow-up of 6 years.
|
Academic Article
|
Kaposi's sarcoma in liver transplant recipients on FK506.
|
Academic Article
|
Tacrolimus and transplantation: a decade in review.
|
Academic Article
|
A prospective, randomized trial of tacrolimus/prednisone versus tacrolimus/prednisone/mycophenolate mofetil in renal transplant recipients.
|
Academic Article
|
Immunosuppressive therapy.
|
Academic Article
|
Prolonged survival of islet allografts following combined therapy with tacrolimus and leflunomide.
|
Academic Article
|
Correlation of rejection episodes with FK 506 dosage, FK 506 level, and steroids following primary orthotopic liver transplant.
|
Academic Article
|
Neurologic complications of FK 506.
|
Academic Article
|
Living-related donor renal transplantation in HIV+ recipients using alemtuzumab preconditioning and steroid-free tacrolimus monotherapy: a single center preliminary experience.
|
Academic Article
|
The latest advances in liver transplantation at the pittsburgh transplantation institute: evolution of FK506, liver-intestinal transplantation, clinical xenotransplantation, and the induction of graft acceptance.
|
Academic Article
|
An analysis of pretransplantation variables associated with long-term allograft outcome in pediatric liver transplant recipients receiving primary tacrolimus (FK506) therapy.
|
Academic Article
|
Tacrolimus pretreatment attenuates preexisting xenospecific immunity and abrogates hyperacute rejection in a presensitized hamster to rat liver transplant model.
|
Academic Article
|
The absence of chronic rejection in pediatric primary liver transplant patients who are maintained on tacrolimus-based immunosuppression: a long-term analysis.
|
Academic Article
|
Reversal of acute cellular rejection after renal transplantation with Campath-1H.
|
Academic Article
|
Outcome after steroid withdrawal in pediatric renal transplant patients receiving tacrolimus-based immunosuppression.
|
Academic Article
|
FK 506 rescue in chronic graft-versus-host-disease after bone marrow transplantation.
|
Academic Article
|
Prolonged prevention of acute graft-versus-host disease after allogeneic bone marrow transplantation by donor pretreatment using FK 506.
|
Academic Article
|
Differential survival of hamster-to-rat liver and cardiac xenografts under FK 506 immunosuppression.
|
Academic Article
|
Metabolic effects of FK 506 in patients with severe psoriasis: short-term follow-up of seven cases.
|
Academic Article
|
Treatment of Cogan's syndrome with FK 506: a case report.
|
Academic Article
|
Posttransplant lymphoproliferative disorders in adult and pediatric renal transplant patients receiving tacrolimus-based immunosuppression.
|
Academic Article
|
Outcome of kidney transplantation under tacrolimus-based immunosuppression in elderly patients.
|
Academic Article
|
Dendritic cell replacement in long-surviving liver and cardiac xenografts.
|
Academic Article
|
Serum cholesterol levels in African Americans after renal transplantation under FK 506 immunosuppression.
|
Academic Article
|
Hamster-to-rat bone marrow xenotransplantation and humoral graft vs. host disease.
|
Academic Article
|
Prospective randomized trial of tacrolimus and prednisone versus tacrolimus, prednisone, and mycophenolate mofetil: complete report on 350 primary adult liver transplantations.
|
Academic Article
|
Long-term survival of heart and liver xenografts with splenectomy and FK 506.
|
Academic Article
|
Nutritional management of intestinal transplant recipients.
|
Academic Article
|
Three-year Outcomes in De Novo Liver Transplant Patients Receiving Everolimus With Reduced Tacrolimus: Follow-Up Results From a Randomized, Multicenter Study.
|
Academic Article
|
Quantitation of immunosuppression by tacrolimus using flow cytometric analysis of interleukin-2 and interferon-gamma inhibition in CD8(-) and CD8(+) peripheral blood T cells.
|
Academic Article
|
Clinical intestinal transplantation: new perspectives and immunologic considerations.
|
Academic Article
|
Outcome after steroid withdrawal in renal transplant patients receiving tacrolimus-based immunosuppression.
|
Academic Article
|
Pretransplant xenogeneic blood transfusion combined with FK 506 prolongs hamster-to-rat liver xenograft survival.
|
Academic Article
|
Mechanisms of protection from humoral rejection by a xenografted liver.
|
Academic Article
|
Pregnancy after liver transplantation with tacrolimus immunosuppression: a single center's experience update at 13 years.
|
Academic Article
|
Randomised trialomania? The multicentre liver transplant trials of tacrolimus.
|
Academic Article
|
A prospective randomized trial of FK506-based immunosuppression after renal transplantation.
|
Academic Article
|
A prospective, randomized trial of FK 506/prednisone vs FK 506/azathioprine/prednisone in renal transplant patients.
|
Academic Article
|
Influence of FK 506 (tacrolimus) on circulating CD4+ T cells expressing CD25 and CD45RA antigens in 19 patients with chronic progressive multiple sclerosis participating in an open label drug safety trial.
|
Academic Article
|
Immunosuppression for liver transplantation in HCV-infected patients: mechanism-based principles.
|
Academic Article
|
Pregnancy after liver transplantation under tacrolimus.
|
Academic Article
|
Replicative senescence of biliary epithelial cells precedes bile duct loss in chronic liver allograft rejection: increased expression of p21(WAF1/Cip1) as a disease marker and the influence of immunosuppressive drugs.
|
Academic Article
|
Two-year experience with FK 506 in pediatric patients.
|
Academic Article
|
Comparative in vitro studies on the immunosuppressive effects of purine and pyrimidine synthesis inhibitors.
|
Academic Article
|
Intestinal transplantation in humans under FK 506.
|
Academic Article
|
Successful hamster-to-rat liver xenotransplantation under FK506 immunosuppression induces unresponsiveness to hamster heart and skin.
|
Academic Article
|
Humoral and cellular immunopathology of hepatic and cardiac hamster-into-rat xenograft rejection. Marked stimulation of IgM++bright/IgD+dull splenic B cells.
|
Academic Article
|
Randomized trial of FK 506/prednisone vs FK 506/azathioprine/prednisone after renal transplantation: preliminary report.
|
Academic Article
|
Orthotopic liver transplantation in high-risk patients: risk factors associated with mortality and infectious morbidity.
|
Academic Article
|
Alopecia as a consequence of tacrolimus therapy.
|
Academic Article
|
Sirolimus for rescue and primary immunosuppression in transplanted children receiving tacrolimus.
|
Academic Article
|
Tacrolimus (FK506) and the pharmaceutical/academic/regulatory gauntlet.
|
Academic Article
|
Management of posttransplant lymphoproliferative disease in pediatric liver transplant recipients receiving primary tacrolimus (FK506) therapy.
|
Academic Article
|
Pediatric renal transplantation under tacrolimus-based immunosuppression.
|
Academic Article
|
A prospective, randomized trial of tacrolimus/prednisone vs tacrolimus/prednisone/mycophenolate mofetil in renal transplantation: 1-year actuarial follow-up.
|
Academic Article
|
Conversion of liver allograft recipients from cyclosporine to FK506 immunosuppressive therapy--a clinicopathologic study of 96 patients.
|
Academic Article
|
Alemtuzumab induction and tacrolimus monotherapy in pancreas transplantation: One- and two-year outcomes.
|
Academic Article
|
Simultaneous pancreas-kidney transplantation at the University of Pittsburgh.
|
Academic Article
|
Preoperative assessment of risk in liver transplantation: a multivariate analysis in 2376 cases of the UW era.
|
Academic Article
|
Experimental animal model of graft-versus-host disease (GVHD) after small-bowel transplantation: characteristics of the model and application to developing treatment strategies.
|
Academic Article
|
Effect of coadministered lopinavir and ritonavir (Kaletra) on tacrolimus blood concentration in liver transplantation patients.
|
Academic Article
|
Tacrolimus for rescue of refractory renal allograft rejection.
|
Academic Article
|
A prospective randomized trial of mycophenolate mofetil in liver transplant recipients with hepatitis C.
|
Academic Article
|
A prospective, randomized trial to compare tacrolimus and prednisone with and without mycophenolate mofetil in patients undergoing renal transplantation: first report.
|
Academic Article
|
Primary adult liver transplantation under tacrolimus: more than 90 months actual follow-up survival and adverse events.
|
Academic Article
|
Effect of hepatic dysfunction and T tube clamping on FK 506 pharmacokinetics and trough concentrations.
|
Academic Article
|
Single-center experience with primary orthotopic liver transplantation with FK 506 immunosuppression.
|
Academic Article
|
FK 506 in solid organ transplantation.
|
Academic Article
|
One thousand consecutive primary orthotopic liver transplants under FK 506: survival and adverse events.
|
Academic Article
|
Kidney transplantation for end-stage renal failure in liver transplant recipients with hepatitis C viral infection.
|
Academic Article
|
Reversibility of tacrolimus-induced posttransplant diabetes: an illustrative case and review of the literature.
|
Academic Article
|
Kidney transplantation under a tolerogenic regimen of recipient pretreatment and low-dose postoperative immunosuppression with subsequent weaning.
|
Academic Article
|
Outcome after steroid withdrawal in adult renal transplant patients receiving tacrolimus-based immunosuppression.
|
Academic Article
|
FK 506 interaction with danazol.
|
Academic Article
|
Use of prostaglandin E1 in crossmatch-negative liver transplant recipients treated with FK 506.
|
Academic Article
|
Posttransplant diabetes mellitus in African Americans after renal transplantation under FK 506 immunosuppression.
|
Academic Article
|
Reasons for long-term use of steroid in primary adult liver transplantation under tacrolimus.
|
Academic Article
|
Porcine partial liver transplantation: a novel model of the "small-for-size" liver graft.
|
Academic Article
|
Tacrolimus without antilymphocyte induction therapy prevents pancreas loss from rejection in 123 consecutive patients.
|
Academic Article
|
Pregnancy after kidney and kidney-pancreas transplantation under tacrolimus: a single center's experience.
|
Academic Article
|
Tacrolimus (FK 506)--a new therapeutic agent for severe recalcitrant psoriasis.
|
Academic Article
|
Low-dose of FK 506 and associated blood levels in allotransplantation of rat liver, heart, and skin.
|
Academic Article
|
A prospective randomized trial of tacrolimus and prednisone versus tacrolimus, prednisone, and mycophenolate mofetil in primary adult liver transplant recipients: an interim report.
|
Academic Article
|
Long-term results of pancreas transplantation under tacrolius immunosuppression.
|
Academic Article
|
Immune modulation in organ allograft recipients by single or multiple donor bone marrow infusions.
|
Academic Article
|
Liver transplantation under tacrolimus in infants, children, adults, and seniors: long-term results, survival, and adverse events in 1000 consecutive patients.
|
Academic Article
|
Clinical outcome of patients infected with hepatitis C virus infection on survival after primary liver transplantation under tacrolimus.
|
Academic Article
|
Stability and sorption of FK 506 in 5% dextrose injection and 0.9% sodium chloride injection in glass, polyvinyl chloride, and polyolefin containers.
|
Academic Article
|
Predicting immunosuppressant dosing in the early postoperative period with noninvasive indocyanine green elimination following orthotopic liver transplantation.
|
Academic Article
|
Effect of t-tube clamping on the pharmacokinetics of mycophenolic acid in liver transplant patients on oral therapy of mycophenolate mofetil.
|
Academic Article
|
Synergistic effect of cold and warm ischemia time on postoperative graft outcome in human liver transplantation.
|
Academic Article
|
FK 506 reverses acute graft-versus-host disease after allogeneic bone marrow transplantation in rats.
|
Academic Article
|
A pilot trial of tacrolimus, sirolimus, and steroids in renal transplant recipients.
|
Academic Article
|
Prevention of graft-versus-host disease following allogeneic bone marrow transplantation in rats using FK506.
|
Academic Article
|
FK 506 dosage in human organ transplantation.
|
Academic Article
|
Studies of the hepatotrophic qualities of FK 506 and CyA.
|
Academic Article
|
Suppression of allograft rejection with FK506. I. Prolonged cardiac and liver survival in rats following short-course therapy.
|
Academic Article
|
Lymphoproliferative disorders arising under immunosuppression with FK 506: initial observations in a large transplant population.
|
Academic Article
|
Use of FK 506 in pediatric patients.
|
Academic Article
|
The side effects of FK 506 in humans.
|
Academic Article
|
Conversion from cyclosporine to FK 506 in liver allograft recipients with cyclosporine-related complications.
|
Academic Article
|
Interaction between tacrolimus and antiretroviral agents in human immunodeficiency virus-positive liver and kidney transplantation patients.
|
Academic Article
|
Functional differentiation of human cytotoxic T lymphocytes in the presence of FK 506 and CyA.
|
Academic Article
|
Assay of FK 506 in plasma.
|
Academic Article
|
Conversion of liver allograft recipients from cyclosporine to FK 506-based immunosuppression: benefits and pitfalls.
|
Academic Article
|
Effects of in vivo treatment with FK506 on natural killer cells in rats.
|
Academic Article
|
Hamster-to-rat liver xenografts protect extrahepatic organs from rejection.
|
Academic Article
|
Posttransplant diabetes in pediatric recipients on tacrolimus.
|
Academic Article
|
Infections with FK 506 immunosuppression: preliminary results with primary therapy.
|
Academic Article
|
Pharmacokinetics of FK 506: preclinical and clinical studies.
|
Academic Article
|
Liver transplantation of American veterans under FK 506 immunosuppression: a preliminary report.
|
Academic Article
|
Effect of tacrolimus and splenectomy on engraftment and GVHD after bone marrow xenotransplantation in the reciprocal hamster to rat animal models.
|
Academic Article
|
Oral glucose tolerance test in liver recipients treated with FK 506.
|
Academic Article
|
FK 506 in steroid-resistant focal sclerosing glomerulonephritis of childhood.
|
Academic Article
|
Liver, kidney, and thoracic organ transplantation under FK 506.
|
Academic Article
|
One hundred ten consecutive primary orthotopic liver transplants under FK 506 in adults.
|
Academic Article
|
Selected topics on FK 506, with special references to rescue of extrahepatic whole organ grafts, transplantation of "forbidden organs," side effects, mechanisms, and practical pharmacokinetics.
|
Academic Article
|
The effect of graft function on FK506 plasma levels, dosages, and renal function, with particular reference to the liver.
|
Academic Article
|
Loss of serum bicarbonate after discordant liver xenotransplantation.
|
Academic Article
|
Pathologic observations in human allograft recipients treated with FK 506.
|
Academic Article
|
The lymphocytotoxic crossmatch in liver transplantation: a clinicopathologic analysis.
|
Academic Article
|
Liver transplantation under cyclosporine: a decade of experience.
|
Academic Article
|
Overview of FK506 in transplantation.
|
Academic Article
|
Almost total absence of chronic rejection in primary pediatric liver transplantation under tacrolimus.
|
Academic Article
|
High-dose cellular IL-10 exacerbates rejection and reverses effects of cyclosporine and tacrolimus in Mouse cardiac transplantation.
|
Academic Article
|
Three years clinical experience with intestinal transplantation.
|
Academic Article
|
Effect of FK 506 on human pancreatic islets following renal subcapsular transplantation in diabetic nude mice.
|
Academic Article
|
Kaposi's sarcoma in two primary liver allograft recipients occurring under FK506 immunosuppression.
|
Academic Article
|
Effect of Early Everolimus-Facilitated Reduction of Tacrolimus on Efficacy and Renal Function in De Novo Liver Transplant Recipients: 24-Month Results for the North American Subpopulation.
|
Grant
|
ORTHOTOPIC LIVER TRANSPLANTATION
|
Academic Article
|
Induction Therapy With Antithymocyte Globulin and Delayed Calcineurin Inhibitor Initiation for Renal Protection in Liver Transplantation: A Multicenter Randomized Controlled Phase II-B Trial.
|